- No strong opportunity cluster is confirmed yet; monitor trend and activity pressure.
OTO
MIL
Week ended 07 Aug 2026
Weekly Investor Report
Otofarma S.P.A. · Healthcare · Medical Devices
Latest close
2.56 EUR
1.6%
latest week
Weekly setup
Weak trend
The weekly trend is not active. Price is -33.0% below the Trend Line and sits at 3.9% of its 52-week range. The latest completed week returned 1.6%, after a -5.2% four-week move. The latest news-sentiment score is 50/100. Near-term considerations: volume confirmation is below normal.
Setup score
14
out of 100
Latest Close
2.56 EUR
7 Aug 2026
1W Return
1.6%
latest completed week
4W Return
-5.2%
short-term follow-through
12W Return
-30.1%
quarterly tape
Trend Breadth
0.0%
0 of 52 weeks active
Volume Ratio
0.6x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Activity pressure is negative, which weakens the current setup.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
1.6%
Latest completed week; four-week move -5.2%.
Indicator stack
0/16
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 20.91%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
50/100
0 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is -33.0% below the Trend Line and sits at 3.9% of its 52-week range. The latest completed week returned 1.6%, after a -5.2% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 0.6x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.0712-week average 0.09
12-week confirmation
Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure0/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.07Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is -5.2% over four weeks, -30.1% over 12 weeks, and -57.0% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year0
Trend breadth0.0%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure-1.96Latest activity-pressure read.
Pressure change17.9%Four-week change in activity pressure.
Leadership-51.39Latest relative-leadership reading.
RS change-Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment50/100
Weighted news tone is neutral across 0 relevant articles.
0 positive · 0 neutral · 0 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-57.1%Distance below the 52-week high.
13-week volatility4.0%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher6 of 2618 weeks finished lower.
Best week+7.1%Week of 20 Mar.
Worst week-8.2%Week of 5 Jun.
Latest week+1.6%Week of 7 Aug.
Shape of recent returns
Strong gains1
Modest gains5
Flat weeks2
Modest losses9
Sharp losses9
Recent vol4.0%13-week weekly-return volatility.
Base vol3.6%52-week weekly-return volatility.
Up/down split14/32Count of positive and negative weeks in the 52-week window.
Average skew3.0% / -3.8%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorIT Healthcare
4-week rank10 / 11
Group average0.5%
Trend breadth36.4%
Trend36.4%active weekly trend signals
MD63.6%positive activity pressure
RS9.1%positive relative leadership
Four-week leaders
IndustryIT Medical Devices
4-week rank3 / 3
Group average-1.9%
Trend breadth33.3%
Trend33.3%active weekly trend signals
MD33.3%positive activity pressure
RS33.3%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape14/100
Trend, activity pressure, participation, and risk combine to a 14/100 tape read.
Indicator analysis10/100Latest 12-week confirmation: trend 0/12, activity pressure 0/12, relative leadership 0/12.
Activity pressure 0.07; No reversal markers Next-Week ExpectancyNegative 20.91%Next-week expectancy is negative with a 20.91% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment50/100Weighted news tone is neutral across 0 relevant articles.
Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 2.56 EUR | 1.6% | 3.82 EUR | 4.46 EUR | -1.96 | -51.39 | 21.6K | Off |
| 31 Jul 2026 | 2.52 EUR | -1.6% | 3.90 EUR | 4.50 EUR | -2.00 | -51.63 | 63.9K | Off |
| 24 Jul 2026 | 2.56 EUR | -7.2% | 3.99 EUR | 4.54 EUR | -2.13 | - | 84.0K | Off |
| 17 Jul 2026 | 2.76 EUR | 2.2% | 4.08 EUR | 4.58 EUR | -2.22 | - | 262.2K | Off |
| 10 Jul 2026 | 2.70 EUR | -3.6% | 4.15 EUR | 4.62 EUR | -2.39 | - | 9.0K | Off |
| 3 Jul 2026 | 2.80 EUR | 0.0% | 4.23 EUR | 4.66 EUR | -2.49 | - | 1.5K | Off |
| 26 Jun 2026 | 2.80 EUR | -4.8% | 4.30 EUR | 4.70 EUR | -2.39 | - | 3.9K | Off |
| 19 Jun 2026 | 2.94 EUR | -7.5% | 4.36 EUR | 4.74 EUR | -2.35 | - | 2.7K | Off |
| 12 Jun 2026 | 3.18 EUR | -5.4% | 4.42 EUR | 4.78 EUR | -2.39 | - | 1.5K | Off |
| 5 Jun 2026 | 3.36 EUR | -8.2% | 4.48 EUR | 4.81 EUR | -2.14 | - | 300 | Off |
| 29 May 2026 | 3.66 EUR | 4.0% | 4.54 EUR | 4.85 EUR | -1.76 | - | 3.6K | Off |
| 22 May 2026 | 3.52 EUR | -3.8% | 4.60 EUR | 4.88 EUR | -1.62 | - | 1.5K | Off |
| 15 May 2026 | 3.66 EUR | -8.0% | 4.67 EUR | 4.91 EUR | -1.34 | - | 5.1K | Off |
| 8 May 2026 | 3.98 EUR | -1.5% | 4.73 EUR | 4.94 EUR | -1.37 | - | 4.2K | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.